Influenza -Like Illness
15
1
1
9
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 15 trials
100.0%
+13.5% vs benchmark
13%
2 trials in Phase 3/4
0%
0 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (15)
Preventing Respiratory Viral Illness Invisibly
Seasonal Influenza Vaccine Effectiveness Study in Kenya
InfluenCEF Study: Study on the Headache Associated With Influenza Infection
Melatonin, Vitamins and Minerals Supplements for the Treatment of Covid-19 and Covid-like Illness
Recombinant Influenza Vaccination in U.S. Nursing Homes
Baloxavir Versus Oseltamivir for Nursing Home Influenza Outbreaks
Efficacy and Safety of Norketotifen in Uncomplicated Influenza-like Illness
Broadening Our Understanding of Early Versus Late Influenza Vaccine Effectiveness
A Trial of Two Mask Systems in Preventing SARS CoV-2 in Healthcare Workers (HCW)
Validation of a CDSA Strategy to Reduce Antibiotic Prescription in Senegal
COVID-19 Pandemic Response Network
Epidemiological Investigation of COVID-19 in Laos Using a One-Health Approach in Human and Animals
Norketotifen for the Treatment of Uncomplicated Influenza-like Illness
Home Testing of Respiratory Illness
How Does the Clinical Tool 'What's Going Around' Affect Clinical Practice